Epstein–Barr virus latent membrane protein 1

Epstein–Barr virus latent membrane protein 1 (LMP1) is an Epstein–Barr virus (EBV) protein that regulates its own expression and the expression of human genes.[1] LMP1 has a molecular weight of approximately 63 kDa, and its expression induces many of the changes associated with EBV infections and activation of primary B cells.[2] LMP1 is the best-documented oncoprotein of the EBV latent gene products, as it is expressed in most EBV-related human cancers.[3]

The structure of LMP1 consists of a short cytoplasmic N-terminus tail, six trans-membrane domains, and a long cytoplasmic C-terminus, which contains three activating domains: CTARt, CTAR2, and CTAR3. Each CTAR domain contains an amino acid sequence that serves as a recognition site for cellular adaptors to bind and trigger a series of signal transduction pathways that can lead to a change in gene expression.[4]

LMP-1 mediates signaling through the tumor necrosis factor-alpha/CD40 pathway.

It is often found in Reed–Sternberg cells.[5][6]

References

  1. ↑ Pratt, Z; Zhang, J; Sugden, B. (2012). "The latent membrane protein 1 (LMP1) oncogene of Epstein–Barr virus can simultaneously induce and inhibit apoptosis in B cells". Journal of Virology 86 (8): 4380–4393. doi:10.1128/JVI.06966-11. PMID 22318153.
  2. ↑ Gupta (2011). "Latent Membrane Protein 1 as a molecular adjuvant for single-cycle lentiviral vaccines". Retrovirology 8 (1): 39. doi:10.1186/1742-4690-8-39.
  3. ↑ Ersing, I; Bernhardt, K; Gewurz, BE (Jun 21, 2013). "NF-κB and IRF7 pathway activation by Epstein-Barr virus Latent Membrane Protein 1.". Viruses (6 ed.) 5: 1587–606. doi:10.3390/v5061587.
  4. ↑ Li, H; Chang, Y (2003). "Epstein–barr virus latent membrane protein 1: Structure and functions.". J Biomed. Sci. 10: 490–504. doi:10.1159/000072376.
  5. ↑ Herling M, Rassidakis GZ, Medeiros LJ; et al. (June 2003). "Expression of Epstein–Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma: associations with presenting features, serum interleukin 10 levels, and clinical outcome". Clin. Cancer Res. 9 (6): 2114–20. PMID 12796376.
  6. ↑ Andersson J (May 2006). "Epstein–Barr virus and Hodgkin's lymphoma". Herpes 13 (1): 12–6. PMID 16732997.


This article is issued from Wikipedia - version of the Thursday, December 24, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.